Axsome's depression drug enters competitive market after U.S. approval

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/26/2026

1. SPY
2. AKAM
3. COST
4. META
5. NVDA
6. ZS
7. AWK
8. DRI
9. ULS
10. VEON

Go back to Axsome's depression drug enters competitive market after U.S. approval
(NASDAQ: AXSM) Delayed: 195.09 -0.94 (0.48%)
Previous Close $196.03    52 Week High $15.74 
Open $197.68    52 Week Low $5.37 
Day High $201.42    P/E N/A 
Day Low $194.35    EPS $0.00 
Volume 838,180